Tofacitinib: New drug in the therapeutic armamentarium in ocular inflammation
Tofacitinib, an oral Janus kinase (JAK) inhibitor, has established efficacy in the management of several autoimmune and inflammatory disorders, including rheumatoid arthritis, psoriatic arthritis, dermatitis, and ulcerative colitis. By inhibiting JAK phosphorylation, tofacitinib modulates cytokine-m...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wolters Kluwer Medknow Publications
2026-06-01
|
| Series: | Indian Journal of Ophthalmology |
| Assuntos: | |
| Acceso en liña: | https://journals.lww.com/10.4103/IJO.IJO_46_26 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|